Related references
Note: Only part of the references are listed.The association between methylene-tetrahydrofolate reductase gene polymorphism and lung cancer risk
Sulhattin Arslan et al.
MOLECULAR BIOLOGY REPORTS (2011)
CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences
Maria N. Timofeeva et al.
CARCINOGENESIS (2009)
Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women
Michele L. Cote et al.
CARCINOGENESIS (2009)
Phase I Metabolic Genes and Risk of Lung Cancer: Multiple Polymorphisms and mRNA Expression
Melissa Rotunno et al.
PLOS ONE (2009)
A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers
Shanbeh Zienolddiny et al.
CARCINOGENESIS (2008)
CyP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women
Kyong-Ah Yoon et al.
LUNG CANCER (2008)
Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer
Parag P. Shah et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: A population-based study
M. L. Cote et al.
LUNG CANCER (2007)
Association between early-onset breast and laryngeal cancers
E Jaworowska et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers:: a population-based study
AS Wenzlaff et al.
CARCINOGENESIS (2005)
Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population
GY Liang et al.
CANCER LETTERS (2005)
Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer
M Sorensen et al.
CANCER LETTERS (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients
MF Wu et al.
TOXICOLOGY LETTERS (2004)
被撤回的出版物: Polymorphisms of the CYP1B1 gene as risk factors for human renal cell cancer(Retracted article. See vol.23, pg.5321, 2017)
M Sasaki et al.
CLINICAL CANCER RESEARCH (2004)
Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1
T Shimada et al.
CANCER SCIENCE (2004)
Cytochrome P4501B1 gene polymorphisms and postmenopausal breast cancer risk
T Rylander-Rudqvist et al.
CARCINOGENESIS (2003)
Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women
Y Miyoshi et al.
BIOMEDICINE & PHARMACOTHERAPY (2003)
Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure
B Schoket et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Human CYP1B1 Leu432Val gene polymorphism:: ethnic distribution in African-Americans, Caucasians and Chinese;: oestradiol hydroxylase activity;: and distribution in prostate cancer cases and control
YM Tang et al.
PHARMACOGENETICS (2000)
Polymorphisms in P450CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol
DN Li et al.
PHARMACOGENETICS (2000)
Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer
J Watanabe et al.
PHARMACOGENETICS (2000)
Share Paper
